# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-04-22)

**Core value:** Physicians can quickly see what new drugs and new indications have been approved and access the complete prescribing information they need to make prescribing decisions.
**Current focus:** Phase 1: Data Pipeline

## Current Position

Phase: 1 of 4 (Data Pipeline)
Plan: 0 of 2 in current phase
Status: Ready to execute
Last activity: 2026-04-23 — Phase 1 planned (2 plans, 2 waves)

Progress: [██░░░░░░░░] 20%

## Performance Metrics

**Velocity:**
- Total plans completed: 0
- Average duration: -
- Total execution time: 0 hours

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| - | - | - | - |

**Recent Trend:**
- Last 5 plans: none
- Trend: N/A

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- [Init]: NMEs + SUPPL approvals mixed in single list with type flag (core differentiator)
- [Init]: Static site with Python pipeline (no frameworks, no Node.js)
- [Init]: systemd timer for weekly data refresh (not cron)

### Pending Todos

None yet.

### Blockers/Concerns

- Phase 1 needs SUPPL efficacy classification values verified against real openFDA data before implementation
- Phase 3 needs label HTML sanitization strategy tested against real FDA label data (malformed tables common in adverse_reactions)

## Deferred Items

Items acknowledged and carried forward from previous milestone close:

| Category | Item | Status | Deferred At |
|----------|------|--------|-------------|
| *(none)* | | | |

## Session Continuity

Last session: 2026-04-22
Stopped at: Roadmap created, ready for Phase 1 planning
Resume file: None